Deborah advises clients on reimbursement and policy strategy for medical devices, diagnostics, biologics and health services by public and private payers. With more than 25 years of health industry experience, Deborah leverages her deep knowledge and strong industry relationships to deliver strategic, operational and policy consultative services to companies of all sizes, from start-ups to Fortune 100 companies. Due to her deep background in working with clients across the healthcare services spectrum, Deborah has a detailed understanding of the market access process and the historical successes to help healthcare clients with emerging and innovative technologies achieve their goals.

For the past decade, Deborah has worked alongside healthcare innovators to advance their market access goals, including:

• Navigating the complex Centers for Medicare and Medicaid Services (CMS) landscape;
• Addressing the challenges and opportunities of bringing e-products to market; and
• Providing insight on the US healthcare system and the health industry.

Deborah also collaborates with clients pursuing Medicare coding, coverage and payment of their groundbreaking, digitally-enabled healthcare solutions and services, including diagnostic tests and medical devices, artificial intelligence (AI)-powered technologies, remote monitoring tools, and other innovative health services. Her work encompasses assessing the various pathways in federal testing and the requirements needed to obtain additional or incremental payment. Deborah has been successful in obtaining favorable payment rates under the Medicare Clinical Laboratory Fee Schedule, incremental payment in the hospital inpatient and outpatient setting, and procedure, product and diagnosis codes.

Prior to joining McDermott+, Deborah was a senior leader at a health technology company focused on the healthcare benefits industry. She also held roles at several consulting firms where she focused on corporate and product strategy for health plans launching new products in the private sector, built health economic models, and analyzed data to assess the effectiveness of federal and state health programs.